• 1
    Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378383.
  • 2
    Oh CK, Jeong HJ, Kim YS et al. Clinical validity of Banff grading of chronic rejection in renal transplantation. Transplant Proc 1996; 28: 14411442.
  • 3
    Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’). Am J Transplant 2007; 7: 518526.
  • 4
    Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: New diagnostic insights and standards. Am J Transplant 2004; 4: 15621566.
  • 5
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria—an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 6
    Marcussen N, Olsen TS, Benediktsson H, Racusen L, Solez K. Reproducibility of the Banff classification of renal allograft pathology. Inter- and intraobserver variation. Transplant 1995; 60: 10831089.
  • 7
    Furness PN, Taub N, Assmann KJ et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805810.
  • 8
    Furness PN, Kirkpatrick U, Taub N, Davies DR, Solez K. A UK-wide trial of the Banff classification of renal transplant pathology in routine diagnostic practice. Nephrol Dial Transplant 1997; 12: 995100.
  • 9
    Furness PN, Levesley J, Luo Z et al. A neural network approach to the biopsy diagnosis of early acute renal transplant rejection. Histopathology 1999; 35: 461467.
  • 10
    Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 2001; 60: 19982012.
  • 11
    Colvin RB. Chronic allograft nephropathy. N Engl J Med 2003; 349: 22882290.
  • 12
    Mengel M, Chapman JR, Cosio FG et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant 2007; 7: 512517.
  • 13
    Gaber LW, Moore LW, Alloway RR et al. Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 1996; 49: 481487.
  • 14
    Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 19301941.
  • 15
    Minervini MI, Torbenson M, Scantlebury V et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). Am J Surg Path 2000; 24: 553558.
  • 16
    Haas M, Kraus ES, Samaniego-Picota M, Racusen LC, Ni W, Eustace JA. Acute renal allograft rejection with intimal arteritis: Histologic predictors of response to therapy and graft survival. Kidney Int 2002; 61: 15161526.
  • 17
    Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125138.
  • 18
    Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 14751489.
  • 19
    Horwitz PA, Tsai EJ, Putt ME et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004; 110: 38153821.
  • 20
    Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: A multiple random validation strategy. Lancet 2005; 365: 488492.
  • 21
    Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102: 1554515550.
  • 22
    Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003; 95: 1418.
  • 23
    Chang HY, Nuyten DS, Sneddon JB et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 2005; 102: 37383743.
  • 24
    Jabs WJ, Sedlmeyer A, Ramassar V et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 15011509.
  • 25
    Einecke G, Melk A, Ramassar V et al. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am J Transplant 2005; 5: 18271836.
  • 26
    Famulski KS, Einecke G, Reeve J et al. Changes in the transcriptome in allograft rejection: IFN-g induced transcripts in mouse kidney allografts. Am J Transplant 2006; 6: 13421354.
  • 27
    Einecke G, Broderick G, Sis B, Halloran PF. Early loss of renal transcripts in kidney allografts: Relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007; 7: 11211130.
  • 28
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 29
    Willinger T, Freeman T, Hasegawa H, McMichael AJ, Callan MF. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol 2005; 175: 58955903.
  • 30
    Hoffmann SC, Hale DA, Kleiner DE et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573581.
  • 31
    Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947954.
  • 32
    Hidalgo S, Reeve F, Einecke M et al. NK cell associated transcripts are selectively increased in human renal antibody-mediated rejection compared to T cell-mediated rejection. Am J Transplant 2007; 7(Suppl 2): 226.
  • 33
    Sis B, Hidalgo LG, Reeve J, Mueller TF, Halloran PF. Endothelial cell-associated transcripts are selectively increased in antibody-mediated rejection in human renal allografts, and correlatewith pathologic features. Am J Transplant 2007; 7(Suppl 2): 209.